197 related articles for article (PubMed ID: 24687028)
1. Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancer.
Reimers MS; Bastiaannet E; Langley RE; van Eijk R; van Vlierberghe RL; Lemmens VE; van Herk-Sukel MP; van Wezel T; Fodde R; Kuppen PJ; Morreau H; van de Velde CJ; Liefers GJ
JAMA Intern Med; 2014 May; 174(5):732-9. PubMed ID: 24687028
[TBL] [Abstract][Full Text] [Related]
2. Aspirin as adjuvant therapy for stage III colon cancer: standard of care?
Neugut AI
JAMA Intern Med; 2014 May; 174(5):739-41. PubMed ID: 24686732
[No Abstract] [Full Text] [Related]
3. Study finds that aspirin improves survival after colon cancer diagnosis.
Kmietowicz Z
BMJ; 2014 Mar; 348():g2476. PubMed ID: 24691102
[No Abstract] [Full Text] [Related]
4. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.
Liao X; Lochhead P; Nishihara R; Morikawa T; Kuchiba A; Yamauchi M; Imamura Y; Qian ZR; Baba Y; Shima K; Sun R; Nosho K; Meyerhardt JA; Giovannucci E; Fuchs CS; Chan AT; Ogino S
N Engl J Med; 2012 Oct; 367(17):1596-606. PubMed ID: 23094721
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer.
Domingo E; Church DN; Sieber O; Ramamoorthy R; Yanagisawa Y; Johnstone E; Davidson B; Kerr DJ; Tomlinson IP; Midgley R
J Clin Oncol; 2013 Dec; 31(34):4297-305. PubMed ID: 24062397
[TBL] [Abstract][Full Text] [Related]
6. The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis.
Frouws MA; Reimers MS; Swets M; Bastiaannet E; Prinse B; van Eijk R; Lemmens VE; van Herk-Sukel MP; van Wezel T; Kuppen PJ; Morreau H; van de Velde CJ; Liefers GJ
PLoS One; 2017; 12(1):e0170775. PubMed ID: 28125730
[TBL] [Abstract][Full Text] [Related]
7. Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis.
Li P; Wu H; Zhang H; Shi Y; Xu J; Ye Y; Xia D; Yang J; Cai J; Wu Y
Gut; 2015 Sep; 64(9):1419-25. PubMed ID: 25239119
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort Study.
Gray RT; Cantwell MM; Coleman HG; Loughrey MB; Bankhead P; McQuaid S; O'Neill RF; Arthur K; Bingham V; McGready C; Gavin AT; Cardwell CR; Johnston BT; James JA; Hamilton PW; Salto-Tellez M; Murray LJ
Clin Transl Gastroenterol; 2017 Apr; 8(4):e91. PubMed ID: 28448072
[TBL] [Abstract][Full Text] [Related]
9. Potential biomarker for aspirin use in colorectal cancer therapy.
Langley RE; Rothwell PM
Nat Rev Clin Oncol; 2013 Jan; 10(1):8-10. PubMed ID: 23207797
[TBL] [Abstract][Full Text] [Related]
10. PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer.
Ogino S; Nosho K; Kirkner GJ; Shima K; Irahara N; Kure S; Chan AT; Engelman JA; Kraft P; Cantley LC; Giovannucci EL; Fuchs CS
J Clin Oncol; 2009 Mar; 27(9):1477-84. PubMed ID: 19237633
[TBL] [Abstract][Full Text] [Related]
11. Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology.
Ogino S; Lochhead P; Giovannucci E; Meyerhardt JA; Fuchs CS; Chan AT
Oncogene; 2014 Jun; 33(23):2949-55. PubMed ID: 23792451
[TBL] [Abstract][Full Text] [Related]
12. Aspirin use and risk of colorectal cancer according to BRAF mutation status.
Nishihara R; Lochhead P; Kuchiba A; Jung S; Yamauchi M; Liao X; Imamura Y; Qian ZR; Morikawa T; Wang M; Spiegelman D; Cho E; Giovannucci E; Fuchs CS; Chan AT; Ogino S
JAMA; 2013 Jun; 309(24):2563-71. PubMed ID: 23800934
[TBL] [Abstract][Full Text] [Related]
13. Examining the impact of regular aspirin use and PIK3CA mutations on survival in stage 2 colon cancer.
Murphy C; Turner N; Wong HL; Sinnathamby M; Tie J; Lee B; Desai J; Skinner I; Christie M; Hutchinson R; Lunke S; Waring P; Gibbs P; Tran B
Intern Med J; 2017 Jan; 47(1):88-98. PubMed ID: 27800646
[TBL] [Abstract][Full Text] [Related]
14. PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies.
Paleari L; Puntoni M; Clavarezza M; DeCensi M; Cuzick J; DeCensi A
Clin Oncol (R Coll Radiol); 2016 May; 28(5):317-26. PubMed ID: 26712086
[TBL] [Abstract][Full Text] [Related]
15. Statin Use After Diagnosis of Colon Cancer and Patient Survival.
Voorneveld PW; Reimers MS; Bastiaannet E; Jacobs RJ; van Eijk R; Zanders MMJ; Herings RMC; van Herk-Sukel MPP; Kodach LL; van Wezel T; Kuppen PJK; Morreau H; van de Velde CJH; Hardwick JCH; Liefers GJ
Gastroenterology; 2017 Aug; 153(2):470-479.e4. PubMed ID: 28512021
[TBL] [Abstract][Full Text] [Related]
16. Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical Trials.
Sinicrope FA; Shi Q; Allegra CJ; Smyrk TC; Thibodeau SN; Goldberg RM; Meyers JP; Pogue-Geile KL; Yothers G; Sargent DJ; Alberts SR
JAMA Oncol; 2017 Apr; 3(4):472-480. PubMed ID: 28006055
[TBL] [Abstract][Full Text] [Related]
17. Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial.
Ogino S; Liao X; Imamura Y; Yamauchi M; McCleary NJ; Ng K; Niedzwiecki D; Saltz LB; Mayer RJ; Whittom R; Hantel A; Benson AB; Mowat RB; Spiegelman D; Goldberg RM; Bertagnolli MM; Meyerhardt JA; Fuchs CS;
J Natl Cancer Inst; 2013 Dec; 105(23):1789-98. PubMed ID: 24231454
[TBL] [Abstract][Full Text] [Related]
18. Aspirin Treatment Effect and Association with PIK3CA Mutation in Breast Cancer: A Biomarker Analysis.
Zhou Y; Simmons J; Jordan CD; Sonbol MB; Maihle N; Tang SC
Clin Breast Cancer; 2019 Oct; 19(5):354-362.e7. PubMed ID: 31262687
[TBL] [Abstract][Full Text] [Related]
19. PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancer.
Sood A; McClain D; Maitra R; Basu-Mallick A; Seetharam R; Kaubisch A; Rajdev L; Mariadason JM; Tanaka K; Goel S
Clin Colorectal Cancer; 2012 Jun; 11(2):143-50. PubMed ID: 22285706
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival.
Mima K; Nishihara R; Yang J; Dou R; Masugi Y; Shi Y; da Silva A; Cao Y; Song M; Nowak J; Gu M; Li W; Morikawa T; Zhang X; Wu K; Baba H; Giovannucci EL; Meyerhardt JA; Chan AT; Fuchs CS; Qian ZR; Ogino S
Clin Cancer Res; 2016 Aug; 22(15):3841-8. PubMed ID: 26957558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
